Autosomal Dominant Tubulointerstitial Kidney Disease
What's New
Last Posted: Jun 20, 2024
- Genomic Testing in Patients with Kidney Failure of an Unknown Cause: a National Australian Study.
Amali C Mallawaarachchi et al. Clin J Am Soc Nephrol 2024 - Genomics in the kidney clinic.
Gabriel T Doctor et al. Clin Med (Lond) 2023 23(3) 246-249 - Cystic Kidney Diseases That Require a Differential Diagnosis from Autosomal Dominant Polycystic Kidney Disease (ADPKD).
Sekine Akinari et al. Journal of clinical medicine 2022 11(21) - An intermediate-effect size variant in UMOD confers risk for chronic kidney disease.
Olinger Eric et al. Proceedings of the National Academy of Sciences of the United States of America 2022 119(33) e2114734119 - Clinical utility of genetic testing in early-onset kidney disease: seven genes are the main players.
Domingo-Gallego Andrea et al. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2021 Feb - Significance of kidney biopsy in autosomal dominant tubulointerstitial kidney disease-UMOD: is kidney biopsy truly nonspecific?
Onoe Tamehito et al. BMC nephrology 2021 Jan 22(1) 1 - Quality of life in patients with autosomal dominant tubulointerstitial kidney disease
.
Bleyer Anthony J et al. Clinical nephrology 2019 Dec 92(6) 302-311 - Outcomes of patient self-referral for the diagnosis of several rare inherited kidney diseases.
Bleyer Anthony J et al. Genetics in medicine : official journal of the American College of Medical Genetics 2019 Jul - Autosomal dominant tubulointerstitial kidney disease
From NCATS Genetic and Rare Diseases Information Center - Autosomal dominant tubulointerstitial kidney disease, MUC1-related
From NCATS Genetic and Rare Diseases Information Center
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: